NASUS PHARMA LTD

Historical 13F Holders

Symbol
NSRX
CUSIP
M7071P109
All holders as of
Q3 2026
Type
Equity
Class
ORD SHS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for M7071P109 since 12/18/2024, newest first.

Filer % of Class Filed
Balyasny Asset Management L.P. 13G/A Amendment 2
10.0% 11/16/2026
Event 9/30/2026
Balyasny Asset Management L.P. 13G/A Amendment 1
10.0% 8/14/2026
Event 6/30/2026
Funicular Funds, LP 13G
5.2% 4/7/2026
Event 3/31/2026
Hershman Ronnie 13G
15.3% 11/13/2025
Event 9/30/2025
Megiddo Dalia 13G 20.9% 11/12/2025
Event 9/30/2025
Udi Gilboa 13G 21.1% 11/10/2025
Event 9/30/2025
Capital Point Ltd. 13G 6.4% 8/20/2025
Event 8/14/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 5 240 k $886k
2026 Q2 10 2.15 M $7.53M
2026 Q1 9 2.17 M $4.83M
2025 Q4 2 2.38 k $21.8k
2025 Q3 2 3.24 k $21.6k